Skip Prichard

JULY 22, 2019

It’s a fascinating study, one that echoes my constant inquiry of the difference between success and failure. You are teaching what separates successful innovators from those who struggle. If Tesla’s ideas ultimately had more impact, then why was Edison so much more successful? Lessons from Tesla versus Edison.

Innovation 80

Innovation Social Capital Reputation How To 80

Harvard Business Review

OCTOBER 26, 2011

Even if most of their investments fail, a few spectacular successes can "make the fund" for a VC. If the IPO window remains open in spite of Solyndra's public failings, we anticipate that a broader set of clean energy startups will achieve successful exits.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

FEBRUARY 22, 2013

Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. Realizing that a rejection from the FDA was possible, Baldino sharply scaled back the Mytrophin program, containing the risk but maintaining an option on the possibility of success. The FDA voted to reject Myotrophin in 1997.

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). In these markets if existing companies don’t rise to the innovation challenge, no one will.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8